An Ontario woman is urging the province to cover a drug that could save her life but costs over $500K
An Ontario woman is urging the government to reconsider insurance eligibility for a drug that could save her life but costs hundreds of thousands of dollars.
Toronto resident Nouma Hammash, 39, grew up in the United Arab Emirates. Diagnosed with spinal muscular atrophy (SMA) at a young age, she has lived most of her life losing the ability to utilize her muscles.
“It’s a slow death,” Hammash told CTV News Toronto during an interview over the phone.
SMA is a rare genetic disease affecting the body’s motor neurons — nerve cells that control voluntary muscle movement. Over time, the muscles weaken and shrink.
“SMA causes progressive weakness in the arms and legs, progressive weakness of breathing muscles, known as respiratory failure, and, in many patients, it also causes problems with swallowing,” Dr. Aaron Izenberg, a neurologist and SMA specialist at Sunnybrook Hospital in Toronto, told CTV News Toronto.
In 2016, Hammash moved to Canada. Now, she works at Spinal Cord Injury Ontario as a mediator and is an advocate for other patients facing similar situations.
However, since Hammash’s arrival in Canada, her condition has worsened and she has yet to find a successful treatment plan.
“At one point, I was able to [get] in and out of bed but now I can’t,” she explained. “I was able to turn over in bed, now I can never do that.”
Hammah says the physical weakness isn’t the only loss she’s mourning.
“There's so many ways in which I’m continuing to lose my power and with that, I lose my independence,” she said.
“We’re not only speaking about the physical death – when the spirit leaves the body – but about the death of [an] independent life.”
In June 2017, Hammash felt she nearly had the solution when Health Canada approved Spinraza for Canadian SMA patients. Spinraza, a brand name of the medication nusinersen, is used to treat spinal muscular atrophy and slows the progression of the disease.
However, her dreams were soon dashed when she found out she wouldn’t be able to access coverage for the costly medication. Without insurance, reimbursement or government coverage, the first year’s worth of Spinraza costs about $700,000.
“I’ve never got a single dose,” Hammash said. When asked why, she explained, “because I’m an adult.”
As of now, Ontario only offers Spinraza coverage to patients under the age of 18, due to a lack of controlled trials and data in older age groups. That eligibility expanded slightly in 2019 to include some adults on a case-by-case basis, but Hammash still does not meet the criteria.
“Basically, for nusinersen, there’s only randomized controlled trial data up until the age of 12,” Izenberg said. “Beyond that, there's still data, but it just hasn't been studied in…placebo-controlled randomized control trials.”
While there’s nothing stopping those trials from taking place, Izenberge said they are “logistically challenging and expensive.” Because Health Canada looks for evidence-based research, when a certain drug is only required by a small population, it can complicate and extend the approval process
“You need huge numbers of patients over a long period of time and I don’t know if that’s ever going to happen,” he said. “That's really the issue – and to pay out of pocket for these medications is just not feasible.”
In a recent interview with CTV News Toronto, Beth Vanstone, an Ontario mother whose child suffers from cystic fibrosis (CF), says conditions like SMA and CF are the reason Canada needs a national framework for rare diseases and new medications as they come out.
“[Cystic fibrosis] is not the only disease that has those challenges – all rare diseases have a lot of challenges – particularly rare diseases that only have a couple of patients in the country or the world.”
She says Canadian health-care and insurance policies aren’t keeping up with the science.
“Science has marched forward,” she said. “Our system, sadly, just hasn’t kept up.”
Meanwhile, Izenberg said he hopes research into the drug will continue.
“Ultimately, what would be amazing is if we get super strong data that will demonstrate an unequivocal benefit,” he said, although admitting he has no concept of if or when this will take place.
However, for SMA patients, time is of the essence and many have already been waiting for years.
“What's going to happen in five years if I'm not able to work and if I'm not able to touch my nose and drink my water – how am I going to do it?” Hammash asked.
Hammash says if she's forced to wait years for clinical data to jusifty her need for Spinraza, it may very well be too late.
“I think I might be dead already.”
CTVNews.ca Top Stories
Man arrested after allegedly caught trespassing at Drake's Bridle Path mansion
Toronto police say a man has been taken into custody after he was allegedly caught trespassing at Drake's mansion in Bridle Path Saturday afternoon.
Wildfire that forced evacuation of Fort Nelson, B.C., caused by tree falling on wires, mayor says
The wildfire that prompted the evacuation of more than 3,000 people near Fort Nelson, B.C., was caused by a tree falling on wires, according to the municipality's mayor.
Eurovision Song Contest final kicks off after protests, backstage chaos and a contestant's expulsion
The 68th Eurovision Song Contest finally got down to musical business Saturday in the Swedish city of Malmo after days of protests and offstage drama that have tipped the feelgood musical celebration into a chaotic pressure cooker overshadowed by the war in Gaza.
Couple randomly attacked, 1 stabbed, by group of teens in Toronto, police say
A man has been transported to hospital after police say he was stabbed in a random attack carried out by a group of teens in Toronto on Friday night.
'I am angry': Alberta farmers will continue fight over world class motorsport resort
The rolling hills leading to the hamlet of Rosebud are dotted with sprawling farms and cattle pastures -- and a sign sporting a simple message: No Race Track.
IN PICTURES Northern lights dance across the night sky in southern Ont.
From London, to Grand Bend, Collingwood and Guelph, here are some highlights of Friday night and Saturday morning's northern lights display.
Ron Ellis, who played over 1,000 games with Maple Leafs, dead at 79
Ron Ellis, who played over 1,000 games with the Toronto Maple Leafs and was a member of Canada's team at the 1972 Summit Series, has died at age 79.
opinion How to use your credit card as a powerful wealth-building tool
Irresponsibly using a credit card can land you in financial trouble, but personal finance columnist Christopher Liew says when used properly, it can be a powerful wealth-building tool that can help grow your credit profile and create new opportunities.
Which Canadian cities have the highest and lowest grocery prices?
Where you live plays a big factor in what you pay at the grocery store. And while it's no secret the same item may have a different price depending on the store, city or province, we wanted to see just how big the differences are, and why.